Insights

More Articles Back to Article

Sanofi, GSK COVID-19 vaccine being reviewed in Europe

The European Medicines Agency has begun a rolling review of Sanofi and GlaxoSmithKline's COVID-19 vaccine, to "assess the compliance of Vidprevtyn with the usual EU standards for effectiveness, safety and quality," the regulator said. The drugmakers hope to have the vaccine approved by the end of this year. Reuters (7/20)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!